Ameriprise Financial Inc Bio N Tech Se Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Ameriprise Financial Inc holds 28,730 shares of BNTX stock, worth $3.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,730

Previous 45,485 36.84%

Holding current value

$3.56 Million

Previous $3.66 Million 6.65%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $1.31 Million - $2.09 Million	-16,755 Reduced 36.84%	28,730 $3.41 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $9,402 - $12,035	117 Added 0.26%	45,485 $3.66 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $174,272 - $220,093	1,959 Added 4.51%	45,368 $4.19 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $379,185 - $470,280	-4,171 Reduced 8.77%	43,409 $4.58 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $134,649 - $170,984	-1,367 Reduced 2.79%	47,580 $5.17 Million
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $14,566 - $18,411	-142 Reduced 0.29%	48,947 $5.28 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $658,323 - $825,361	5,371 Added 12.29%	49,089 $6.12 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $1.75 Million - $2.76 Million	14,814 Added 51.25%	43,718 $6.57 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $458,135 - $657,181	-3,589 Reduced 11.05%	28,904 $3.9 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $42,521 - $64,252	-345 Reduced 1.05%	32,493 $4.84 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $1.34 Million - $2.47 Million	10,649 Added 47.99%	32,838 $5.6 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $3.3 Million - $5.52 Million	15,236 Added 219.13%	22,189 $5.72 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $915,976 - $1.99 Million	4,448 Added 177.56%	6,953 $1.68 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $35.3 Million - $75.2 Million	-311,578 Reduced 99.2%	2,505 $561,000
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $8.84 Million - $12.3 Million	-103,057 Reduced 24.71%	314,083 $34.3 Million
Q4 2020 Feb 12, 2021	SELL	$72.71 - $129.54 $16.4 Million - $29.3 Million	-225,972 Reduced 35.14%	417,140 $34 Million
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $37.2 Million - $67 Million	643,112 New	643,112 $44.5 Million

Others Institutions Holding BNTX

# of Institutions

360

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Bio N Tech Se Transaction History